New hope for kids with Tough-to-Treat leukemia
NCT ID NCT05645718
Summary
This study is testing a combination of several cancer drugs to see if they can help control a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL) in children and young adults whose cancer has come back or did not respond to previous treatment. The trial will enroll up to 27 participants aged 1 to 25 years old. Researchers want to see if this new drug combination is safe and effective at putting the cancer into remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.